Sierra Sees Momelotinib ‘Sweet Spot’ In Anemic Myelofibrosis Population

 
• By Alaric DeArment
3-D Rendering Red Blood Cells
Sierra announced data from the Phase III MOMENTUM study of momelotinib in myelofibrosis • Source: Shutterstock

More from Strategy

More from Business